Yahoo! Finance: PRX News

According To Credit Suisse Vice President, Certain Health Care Stocks To Benefit Greatly From U.S. Legislation: Which Companies Stand To Benefit The Most? (Wall Street Transcript)

Mon, 21 Dec 2009 22:40:00 Etc/GMT

67 WALL STREET, New York - December 21, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

PAR PHARMACEUTICAL COMPANIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)

Fri, 18 Dec 2009 22:02:05 Etc/GMT

Large And Small Cap Picks In The Health Care Space: Credit Suisse Analyst Guides Investors On Which Stocks Are A Good Buy (Wall Street Transcript)

Mon, 14 Dec 2009 16:55:00 Etc/GMT

67 WALL STREET, New York - December 14, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Equity Valuations In The Health Care Service Space Not To Be Affected By Unemployment Levels, According To BMO Analyst (Wall Street Transcript)

Thu, 10 Dec 2009 20:14:00 Etc/GMT

Which Health Care Sectors Will Benefit Under Impending Legislation? The Answer According To Lazard Capital (Wall Street Transcript)

Wed, 9 Dec 2009 14:14:00 Etc/GMT

67 WALL STREET, New York - December 9, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Herbalife Ltd. (HLF): Zacks Rank Buy (Zacks.com)

Mon, 7 Dec 2009 06:00:00 Etc/GMT

Zacks Releases Four Powerful ''Buy'' Stocks: American Superconductor Corp, Wolverine World Wide Inc., Par Pharmaceutical Cos. and Jones Apparel Group Inc. (Zacks.com)

Fri, 4 Dec 2009 16:03:40 Etc/GMT

Par Pharmaceutical Cos. (PRX): Zacks Rank Buy (Zacks.com)

Fri, 4 Dec 2009 06:00:00 Etc/GMT

PAR PHARMACEUTICAL COMPANIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial State (EDGAR Online)

Thu, 3 Dec 2009 16:36:21 Etc/GMT

Stock Picks: SNTS Up; WAG Down (at SmartMoney.com)

Wed, 2 Dec 2009 15:51:00 Etc/GMT

Build Your Fortune With These Winners (at Motley Fool)

Wed, 25 Nov 2009 20:00:32 Etc/GMT

Par Pharma buys back $30.8M in senior notes (AP)

Wed, 25 Nov 2009 17:31:35 Etc/GMT

Par Pharmaceuticals Cos. said Wednesday it bought $30.8 million in senior notes through a tender offer. Earlier this month, the company had offered to buy back up to $65 million in convertible senior notes due 2010.

Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender Offer (PR Newswire)

Wed, 25 Nov 2009 14:00:00 Etc/GMT

Par Pharmaceutical Companies, Inc. today announced the results of its "Modified Dutch Auction" tender offer, in which Par offered to purchase, for cash, up to $65,000,000 aggregate principal amount, or up to approximately 82.7%, of its outstanding 2.875% Senior Subordinated Convertible Notes due 2010.

Drugmaker Par Shapes A Base But Needs Time (Investor's Business Daily)

Fri, 20 Nov 2009 23:22:11 Etc/GMT

Generic and branded drugmaker Par Pharmaceutical notched a 52-week high in mid-October.

Par Pharmaceutical to Host Analyst Day on December 3rd (PR Newswire)

Mon, 16 Nov 2009 21:15:00 Etc/GMT

Par Pharmaceutical Companies, Inc. will hold an Analyst Day from 9:00am to 12:00pm EST on December 3, 2009 at its Spring Valley, NY manufacturing facility.

Par Pharma gets FDA approval for generic Ultram ER (AP)

Mon, 16 Nov 2009 15:42:12 Etc/GMT

Par Pharmaceutical Co. said Monday it received marketing approval for a generic version of Johnson & Johnson's extended-release chronic pain drug Ultram ER, and has started shipping the drug.

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER (PR Newswire)

Mon, 16 Nov 2009 13:00:00 Etc/GMT

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for the 100mg and 200mg strengths of tramadol ER.

PAR PHARMACEUTICAL COMPANIES, INC. Financials (EDGAR Online Financials)

Fri, 13 Nov 2009 14:05:41 Etc/GMT

[$$] Biotech Stock Mailbag: Cardium Therapeutics (at RealMoney by TheStreet.com)

Fri, 13 Nov 2009 10:00:29 Etc/GMT

New Star Analyst Rankings for PHARMACUTICAL CO (StarMine)

Tue, 10 Nov 2009 14:24:50 Etc/GMT